Mice overexpressing β-1,4-Galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis.

Glycosylation is an essential post-translational modification, which determines the function of proteins and important processes such as inflammation. β-1,4-galactosyltransferase I (βGalT1) is a key enzyme involved in the addition of galactose moieties to glycoproteins. Intestinal mucins are glycopr...

Full description

Bibliographic Details
Main Authors: Valerie Vanhooren, Roosmarijn E Vandenbroucke, Sylviane Dewaele, Evelien Van Hamme, Jody J Haigh, Tino Hochepied, Claude Libert
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3855152?pdf=render
_version_ 1819069759151407104
author Valerie Vanhooren
Roosmarijn E Vandenbroucke
Sylviane Dewaele
Evelien Van Hamme
Jody J Haigh
Tino Hochepied
Claude Libert
author_facet Valerie Vanhooren
Roosmarijn E Vandenbroucke
Sylviane Dewaele
Evelien Van Hamme
Jody J Haigh
Tino Hochepied
Claude Libert
author_sort Valerie Vanhooren
collection DOAJ
description Glycosylation is an essential post-translational modification, which determines the function of proteins and important processes such as inflammation. β-1,4-galactosyltransferase I (βGalT1) is a key enzyme involved in the addition of galactose moieties to glycoproteins. Intestinal mucins are glycoproteins that protect the gut barrier against invading pathogens and determine the composition of the intestinal microbiota. Proper glycosylation of mucus is important in this regard. By using ubiquitously expressing βGalT1 transgenic mice, we found that this enzyme led to strong galactosylation of mucus proteins, isolated from the gut of mice. This galactosylation was associated with a drastic change in composition of gut microbiota, as TG mice had a significantly higher Firmicutes to Bacteroidetes ratio. TG mice were strongly protected against TNF-induced systemic inflammation and lethality. Moreover, βGalT1 transgenic mice were protected in a model of DSS-induced colitis, at the level of clinical score, loss of body weight, colon length and gut permeability. These studies put βGalT1 forward as an essential protective player in exacerbated intestinal inflammation. Optimal galactosylation of N-glycans of mucus proteins, determining the bacterial composition of the gut, is a likely mechanism of this function.
first_indexed 2024-12-21T16:55:09Z
format Article
id doaj.art-8200ea6930334cd8902d314e06824299
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T16:55:09Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8200ea6930334cd8902d314e068242992022-12-21T18:56:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01812e7988310.1371/journal.pone.0079883Mice overexpressing β-1,4-Galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis.Valerie VanhoorenRoosmarijn E VandenbrouckeSylviane DewaeleEvelien Van HammeJody J HaighTino HochepiedClaude LibertGlycosylation is an essential post-translational modification, which determines the function of proteins and important processes such as inflammation. β-1,4-galactosyltransferase I (βGalT1) is a key enzyme involved in the addition of galactose moieties to glycoproteins. Intestinal mucins are glycoproteins that protect the gut barrier against invading pathogens and determine the composition of the intestinal microbiota. Proper glycosylation of mucus is important in this regard. By using ubiquitously expressing βGalT1 transgenic mice, we found that this enzyme led to strong galactosylation of mucus proteins, isolated from the gut of mice. This galactosylation was associated with a drastic change in composition of gut microbiota, as TG mice had a significantly higher Firmicutes to Bacteroidetes ratio. TG mice were strongly protected against TNF-induced systemic inflammation and lethality. Moreover, βGalT1 transgenic mice were protected in a model of DSS-induced colitis, at the level of clinical score, loss of body weight, colon length and gut permeability. These studies put βGalT1 forward as an essential protective player in exacerbated intestinal inflammation. Optimal galactosylation of N-glycans of mucus proteins, determining the bacterial composition of the gut, is a likely mechanism of this function.http://europepmc.org/articles/PMC3855152?pdf=render
spellingShingle Valerie Vanhooren
Roosmarijn E Vandenbroucke
Sylviane Dewaele
Evelien Van Hamme
Jody J Haigh
Tino Hochepied
Claude Libert
Mice overexpressing β-1,4-Galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis.
PLoS ONE
title Mice overexpressing β-1,4-Galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis.
title_full Mice overexpressing β-1,4-Galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis.
title_fullStr Mice overexpressing β-1,4-Galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis.
title_full_unstemmed Mice overexpressing β-1,4-Galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis.
title_short Mice overexpressing β-1,4-Galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis.
title_sort mice overexpressing β 1 4 galactosyltransferase i are resistant to tnf induced inflammation and dss induced colitis
url http://europepmc.org/articles/PMC3855152?pdf=render
work_keys_str_mv AT valerievanhooren miceoverexpressingb14galactosyltransferaseiareresistanttotnfinducedinflammationanddssinducedcolitis
AT roosmarijnevandenbroucke miceoverexpressingb14galactosyltransferaseiareresistanttotnfinducedinflammationanddssinducedcolitis
AT sylvianedewaele miceoverexpressingb14galactosyltransferaseiareresistanttotnfinducedinflammationanddssinducedcolitis
AT evelienvanhamme miceoverexpressingb14galactosyltransferaseiareresistanttotnfinducedinflammationanddssinducedcolitis
AT jodyjhaigh miceoverexpressingb14galactosyltransferaseiareresistanttotnfinducedinflammationanddssinducedcolitis
AT tinohochepied miceoverexpressingb14galactosyltransferaseiareresistanttotnfinducedinflammationanddssinducedcolitis
AT claudelibert miceoverexpressingb14galactosyltransferaseiareresistanttotnfinducedinflammationanddssinducedcolitis